Literature DB >> 19217015

Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity.

Masaki Kobayashi1, Yasuyuki Shibuya, Junichiro Takeuchi, Maho Murata, Hiroaki Suzuki, Satoshi Yokoo, Masahiro Umeda, Yasuhiro Minami, Takahide Komori.   

Abstract

In this study, the expressions of Ror2 in the normal mucosa, the epithelium dysplasia, and squamous cell carcinoma (SCC) of the oral cavity were investigated, and possible differences in the expression patterns of Ror2 and of p53, Ki67, or PCNA were examined. In Western blotting analyses, Ror2 expression in oral cancer was significantly higher than that in the normal oral mucosa. Immunohistochemically, Ror2 was localized on the plasmalemma and in the rough endoplasmic reticulum (rER). The tissue area with an Ror2-positive expression tended to differ from the area with a positive expression of p53, ki67, or PCNA, and the number of cells with an Ror2 expression tended to increase as the degree of malignancy rose in the epithelial tissues. These results suggest that Ror2 was not related to cell proliferation, but rather associated with cell polarity and cell motility, and that it was also closely associated with the degree of malignancy in oral epithelial tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217015     DOI: 10.1016/j.tripleo.2008.08.018

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  23 in total

1.  Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.

Authors:  Sean S Q Ma; Claire E Henry; Estelle Llamosas; Rupert Higgins; Benjamin Daniels; Luke B Hesson; Nicholas J Hawkins; Robyn L Ward; Caroline E Ford
Journal:  Virchows Arch       Date:  2016-09-08       Impact factor: 4.064

Review 2.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

3.  Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression.

Authors:  Jianjun Huang; Ying Shi; Hui Li; Dunyong Tan; Meisongzhu Yang; Xiang Wu
Journal:  Oncol Lett       Date:  2015-10-12       Impact factor: 2.967

4.  Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma.

Authors:  Tricia M Wright; W Kimryn Rathmell
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

5.  ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling.

Authors:  Likun Yan; Qingguo Du; Jianfeng Yao; Ruiting Liu
Journal:  Exp Ther Med       Date:  2016-11-08       Impact factor: 2.447

6.  Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.

Authors:  Ming Geng; Yong-Cheng Cao; Ying-Jian Chen; Hui Jiang; Li-Quan Bi; Xiao-Hong Liu
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

7.  Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer.

Authors:  Ester Lara; Vincenzo Calvanese; Covadonga Huidobro; Agustin F Fernández; Angela Moncada-Pazos; Alvaro J Obaya; Oscar Aguilera; José Manuel González-Sancho; Laura Sánchez; Aurora Astudillo; Alberto Muñoz; Carlos López-Otín; Manel Esteller; Mario F Fraga
Journal:  Mol Cancer       Date:  2010-06-30       Impact factor: 27.401

8.  Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.

Authors:  Neal R Rasmussen; Tricia M Wright; Samira A Brooks; Kathryn E Hacker; Zufan Debebe; Adam B Sendor; Matthew P Walker; Michael Ben Major; Jennifer Green; Geoffrey M Wahl; W Kimryn Rathmell
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

Review 9.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

Review 10.  Ror2 as a therapeutic target in cancer.

Authors:  Zufan Debebe; W Kimryn Rathmell
Journal:  Pharmacol Ther       Date:  2015-01-19       Impact factor: 13.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.